Right for the Test

Actress Angelina Jolie wrote an op-ed in the New York Times in 2013 explaining her decision to undergo a preventive double mastectomy after learning that she carried a BRCA1 gene mutation.

This revelation, Canadian researchers reported at American Society of Clinical Oncology Breast Cancer Symposium, not only spurred more women to seek genetic counseling, but mostly drove women at high risk of the disease to pursue testing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.